Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
Amanda Mocroft(University of Copenhagen), Lene Ryom(University of Copenhagen), Ole Kirk(University of Copenhagen), Jacqueline Neuhaus(University of Minnesota), Deborah Wentworth(University of Minnesota), Matthew Law(UNSW Sydney), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Olivier Moranne(US Forest Service), Margaret Johnson(Duke University), Christoph A. Fux(Kantonsspital Aarau), Phillipe Morlat(Université de Bordeaux), Peter Reiss(Amsterdam Institute for Global Health and Development), Michael J. Ross(Icahn School of Medicine at Mount Sinai), Colette Smith(MRC Clinical Trials Unit at UCL)
Cited by 159
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k